{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:39Z","timestamp":1786987659537,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cvsm.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:31:22Z","timestamp":1537781482000},"page":"67-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Canine and Feline Cutaneous Epitheliotropic Lymphoma and Cutaneous Lymphocytosis"],"prefix":"10.1016","volume":"49","author":[{"given":"Kathryn A.","family":"Rook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2018.08.007_bib1","series-title":"Muller & Kirk's small animal dermatology","first-page":"938","author":"Miller","year":"2013"},{"key":"10.1016\/j.cvsm.2018.08.007_bib2","series-title":"Skin diseases of the dog and cat: clinical and histopathologic diagnosis","first-page":"932","author":"Gross","year":"2005"},{"key":"10.1016\/j.cvsm.2018.08.007_bib3","series-title":"Skin tumors of the dog and cat","first-page":"252","article-title":"Cutaneous lymphosarcoma","year":"1998"},{"issue":"6","key":"10.1016\/j.cvsm.2018.08.007_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1939-1676.2006.tb00756.x","article-title":"Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999\u20132004)","volume":"20","author":"Risbon","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1939-1676.2006.tb02833.x","article-title":"CCNU in the treatment of canine epitheliotropic lymphoma","volume":"20","author":"Williams","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2018.08.007_bib6","series-title":"Advances in veterinary dermatology","first-page":"273","article-title":"Canine cutaneous lymphosarcoma epitheliotropic and non epitheliotropic, a retrospective study","author":"Beale","year":"1993"},{"issue":"4","key":"10.1016\/j.cvsm.2018.08.007_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1939-165X.1997.tb00735.x","article-title":"Cutaneous T-cell lymphoma with S\u00e9zary syndrome in a dog","volume":"26","author":"Foster","year":"1997","journal-title":"Vet Clin Pathol"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib8","first-page":"97","article-title":"Epitheliotropic cutaneous lymphoma (mycosis fungoides) in a dog","volume":"7","author":"Bhang","year":"2006","journal-title":"J\u00a0Vet Sci"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9975(05)80091-X","article-title":"Immunophenotypic characterization of cutaneous lymphoid neoplasia in the dog and cat","volume":"112","author":"Day","year":"1995","journal-title":"J\u00a0Comp Pathol"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib10","first-page":"421","article-title":"Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T\u00a0cells","volume":"144","author":"Moore","year":"1994","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib11","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/vde.12504","article-title":"Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015)","volume":"29","author":"Chan","year":"2018","journal-title":"Vet Dermatol"},{"issue":"4","key":"10.1016\/j.cvsm.2018.08.007_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-3164.2009.00760.x","article-title":"Canine cutaneous epitheliotropic T-cell lymphoma with vesiculobullous lesions resembling human bullous mycosis fungoides","volume":"20","author":"Bizikova","year":"2009","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.cvsm.2018.08.007_bib13","series-title":"Fitzpatrick's dermatology in general medicine","first-page":"136","author":"Fitzpatrick","year":"2008"},{"issue":"5","key":"10.1016\/j.cvsm.2018.08.007_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11912-006-0061-1","article-title":"Mycosis fungoides and Sezary syndrome: an update","volume":"8","author":"Kim","year":"2006","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"10.1016\/j.cvsm.2018.08.007_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0738-081X(94)90216-X","article-title":"Cutaneous lymphomas in companion animals","volume":"12","author":"Moore","year":"1994","journal-title":"Clin Dermatol"},{"issue":"9616","key":"10.1016\/j.cvsm.2018.08.007_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":"Mycosis fungoides and Sezary syndrome","volume":"371","author":"Hwang","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5829.2008.00176.x","article-title":"Canine cutaneous epitheliotropic T-cell lymphoma: a review","volume":"7","author":"Fontaine","year":"2009","journal-title":"Vet Comp Oncol"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-3164.2009.00793.x","article-title":"Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases","volume":"21","author":"Fontaine","year":"2010","journal-title":"Vet Dermatol"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-3164.2007.00582.x","article-title":"Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: a retrospective case-control study","volume":"18","author":"Santoro","year":"2007","journal-title":"Vet Dermatol"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-3164.2000.00190.x","article-title":"Comparison of T-lymphocyte proliferation in canine epitheliotropic lymphosarcoma and benign lymphocytic dermatoses","volume":"11","author":"Murphy","year":"2000","journal-title":"Vet Dermatol"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/104063871002200104","article-title":"Improved polymerase chain reaction-based method to detect early-stage epitheliotropic T-cell lymphoma (mycosis fungoides) in formalin-fixed, paraffin-embedded skin biopsy specimens of the dog","volume":"22","author":"Chaubert","year":"2010","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"4","key":"10.1016\/j.cvsm.2018.08.007_bib22","first-page":"761","article-title":"Immunophenotypic and antigen receptor gene rearrangement analysis in T\u00a0cell neoplasia","volume":"134","author":"Knowles","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cvsm.2018.08.007_bib23","series-title":"Cellular and molecular immunology","author":"Abbas","year":"2018"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-0560.2008.01259.x","article-title":"CD8-positive mycosis fungoides and primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma","volume":"36","author":"Diwan","year":"2009","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T\u00a0cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.cvsm.2018.08.007_bib26","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.cvsm.2018.08.007_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1034\/j.1600-0560.2002.290804.x","article-title":"Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas","volume":"29","author":"Lu","year":"2002","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.cvsm.2018.08.007_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses","volume":"94","author":"Rook","year":"1999","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2018.08.007_bib30","first-page":"16","article-title":"Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis","volume":"107","author":"Rook","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.cvsm.2018.08.007_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0889-8588(03)00109-6","article-title":"Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2","volume":"17","author":"Rook","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cvsm.2018.08.007_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1749-6632.2001.tb03721.x","article-title":"The role for interleukin-12 therapy of cutaneous T\u00a0cell lymphoma","volume":"941","author":"Rook","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1523-1747.2002.01646.x","article-title":"Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T\u00a0cell lymphoma","volume":"118","author":"Zaki","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cvsm.2018.08.007_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vetimm.2016.03.018","article-title":"Evaluation of CD25-positive cells in relation to the subtypes and prognoses in various lymphoid tumours in dogs","volume":"173","author":"Mizutani","year":"2016","journal-title":"Vet Immunol Immunopathol"},{"issue":"6021","key":"10.1016\/j.cvsm.2018.08.007_bib35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/315669a0","article-title":"Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes","volume":"315","author":"Lowenthal","year":"1985","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.jid.5700122","article-title":"CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma","volume":"126","author":"Talpur","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/10428194.2013.806658","article-title":"Clinical features of de novo CD25-positive follicular lymphoma","volume":"55","author":"Fujiwara","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.vetimm.2011.08.012","article-title":"Gene transcription analysis in lesional skin of canine epitheliotropic cutaneous lymphoma using quantitative real-time RT-PCR","volume":"144","author":"Chimura","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.cvsm.2018.08.007_bib39","first-page":"754","article-title":"The behavior of epidermotropic lymphoma in twenty-five dogs","volume":"30","author":"Wilcock","year":"1989","journal-title":"Can Vet J"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1040638716637642","article-title":"Cutaneous epitheliotropic T-cell lymphoma with systemic dissemination in a dog","volume":"28","author":"Mineshige","year":"2016","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V99.3.800","article-title":"Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients","volume":"99","author":"Fink-Puches","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib42","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cvsm.2018.08.007_bib43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12917-017-0978-7","article-title":"Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic","volume":"13","author":"Laprais","year":"2017","journal-title":"BMC Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3835(92)90016-O","article-title":"Linoleate produces remission in canine mycosis fungoides","volume":"64","author":"Iwamoto","year":"1992","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2460\/javma.1993.202.03.387","article-title":"Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs","volume":"202","author":"White","year":"1993","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cvsm.2018.08.007_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002800050591","article-title":"Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors","volume":"39","author":"Vail","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.cvsm.2018.08.007_bib48","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jvim.12429","article-title":"Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma","volume":"28","author":"Morges","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2018.08.007_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bcp.2018.05.010","article-title":"Tanovea(R) for the treatment of lymphoma in dogs","volume":"154","author":"De Clercq","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib50","first-page":"e65","article-title":"Total skin electron therapy as treatment for epitheliotropic lymphoma in a dog","volume":"28","author":"Domenico","year":"2017","journal-title":"Vet Dermatol"},{"issue":"5","key":"10.1016\/j.cvsm.2018.08.007_bib51","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1939-1676.2010.0571.x","article-title":"Immunohistochemical detection of retinoid receptors in tumors from 30 dogs diagnosed with cutaneous lymphoma","volume":"24","author":"De Mello","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2018.08.007_bib52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaad.2009.02.035","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"62","author":"Gormley","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.cvsm.2018.08.007_bib53","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.cvsm.2018.08.007_bib54","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2460\/ajvr.69.7.938","article-title":"Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines","volume":"69","author":"Kisseberth","year":"2008","journal-title":"Am J Vet Res"},{"issue":"8","key":"10.1016\/j.cvsm.2018.08.007_bib55","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1078-0432.CCR-06-2672","article-title":"Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma","volume":"13","author":"Mann","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.cvsm.2018.08.007_bib56","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-3164.2011.00972.x","article-title":"Cutaneous epitheliotropic T-cell lymphoma in the cat: a review of the literature and five new cases","volume":"22","author":"Fontaine","year":"2011","journal-title":"Vet Dermatol"},{"issue":"12","key":"10.1016\/j.cvsm.2018.08.007_bib57","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2460\/ajvr.1979.40.12.1805","article-title":"Feline skin lymphoma: characterization of tumor and identification of tumor-stimulating serum factor(s)","volume":"40","author":"Legendre","year":"1979","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5326\/0440144","article-title":"Sezary syndrome in a cat","volume":"44","author":"Wood","year":"2008","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"4","key":"10.1016\/j.cvsm.2018.08.007_bib59","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2460\/javma.1994.204.04.606","article-title":"Cutaneous T-cell lymphoma in a cat","volume":"204","author":"Tobey","year":"1994","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.08.007_bib60","first-page":"491","article-title":"Cutaneous lymphosarcoma in the cat: a report of nine cases","volume":"20","author":"Caciolo","year":"1984","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2018.08.007_bib61","first-page":"199","article-title":"Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age","volume":"60","author":"Jackson","year":"1996","journal-title":"Can J Vet Res"},{"issue":"6","key":"10.1016\/j.cvsm.2018.08.007_bib62","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/104063870802000623","article-title":"Perforin expression in feline epitheliotropic cutaneous lymphoma","volume":"20","author":"Neta","year":"2008","journal-title":"J\u00a0Vet Diagn Invest"},{"key":"10.1016\/j.cvsm.2018.08.007_bib63","first-page":"505","article-title":"A\u00a0case of mycosis fungoides in a cat and literature review","volume":"19","author":"Caciolo","year":"1983","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"key":"10.1016\/j.cvsm.2018.08.007_bib64","first-page":"97","article-title":"Mycosis fungoides in two cats","volume":"25","author":"Baker","year":"1989","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"1","key":"10.1016\/j.cvsm.2018.08.007_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-3164.2004.00352.x","article-title":"Clinical, morphological and immunohistochemical characterization of cutaneous lymphocytosis in 23 cats","volume":"15","author":"Gilbert","year":"2004","journal-title":"Vet Dermatol"},{"issue":"9","key":"10.1016\/j.cvsm.2018.08.007_bib66","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1098612X14545275","article-title":"Feline cutaneous lymphocytosis: case report and summary of the literature","volume":"16","author":"Pariser","year":"2014","journal-title":"J\u00a0Feline Med Surg"},{"issue":"5\u20136","key":"10.1016\/j.cvsm.2018.08.007_bib67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-3164.2009.00833.x","article-title":"Indolent cutaneous T-cell lymphoma presenting as cutaneous lymphocytosis in dogs","volume":"20","author":"Affolter","year":"2009","journal-title":"Vet Dermatol"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561618300974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561618300974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:44:34Z","timestamp":1759283074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561618300974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0195561618300974"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2018.08.007","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canine and Feline Cutaneous Epitheliotropic Lymphoma and Cutaneous Lymphocytosis","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}